Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Deroisy

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Experimental Gerontology|January 1, 1990
Calcitonin and postmenopausal bone lossJ Y Reginster, R Deroisy, M P Lecart, et al.
The American Journal of Medicine|May 1, 1995
A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone lossJ Y Reginster, R Deroisy, M P Lecart, et al.
Osteoarthritis and Cartilage|August 8, 2007
Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trialsO Bruyere, K Pavelka, L C Rovati, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 15, 1999
High prevalence of low femoral bone mineral density in elderly women living in nursing homes or community-dwelling: a plausible role of increased parathyroid hormone secretionJ Y Reginster, R Deroisy, H Pirenne, et al.
Lancet (London, England)|December 26, 1987
1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitoninJ Y Reginster, D Denis, A Albert, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 24, 2015
A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periodsO Bruyère, R Deroisy, N Dardenne, et al.
Bone|October 12, 2001
Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from BelgiumW Ben Sedrine, J P Devogelaer, J M Kaufman, et al.
Clinical and Experimental Rheumatology|March 10, 2004
Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphateS Christgau, Y Henrotin, L B Tankó, et al.
Revue Medicale De Liege|January 1, 1997
[Prevention of osteoporosis in Liège. Evaluation of a trial between general practitioners and university specialists (1)]J Y Reginster, R Deroisy, B Zegels, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of boneJ Y Reginster, C Gennari, C Mautalen, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Experimental Gerontology|January 1, 1990
Calcitonin and postmenopausal bone lossJ Y Reginster, R Deroisy, M P Lecart, et al.
The American Journal of Medicine|May 1, 1995
A double-blind, placebo-controlled, dose-finding trial of intermittent nasal salmon calcitonin for prevention of postmenopausal lumbar spine bone lossJ Y Reginster, R Deroisy, M P Lecart, et al.
Osteoarthritis and Cartilage|August 8, 2007
Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trialsO Bruyere, K Pavelka, L C Rovati, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 15, 1999
High prevalence of low femoral bone mineral density in elderly women living in nursing homes or community-dwelling: a plausible role of increased parathyroid hormone secretionJ Y Reginster, R Deroisy, H Pirenne, et al.
Lancet (London, England)|December 26, 1987
1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitoninJ Y Reginster, D Denis, A Albert, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 24, 2015
A phase IV, two-armed, randomized, cross-over study comparing compliance with once-a-month administration of vitamin D3 to compliance with daily administration of a fixed-dose combination of vitamin D3 and calcium during two 6-month periodsO Bruyère, R Deroisy, N Dardenne, et al.
Bone|October 12, 2001
Evaluation of the simple calculated osteoporosis risk estimation (SCORE) in a sample of white women from BelgiumW Ben Sedrine, J P Devogelaer, J M Kaufman, et al.
Clinical and Experimental Rheumatology|March 10, 2004
Osteoarthritic patients with high cartilage turnover show increased responsiveness to the cartilage protecting effects of glucosamine sulphateS Christgau, Y Henrotin, L B Tankó, et al.
Revue Medicale De Liege|January 1, 1997
[Prevention of osteoporosis in Liège. Evaluation of a trial between general practitioners and university specialists (1)]J Y Reginster, R Deroisy, B Zegels, et al.
Scandinavian Journal of Rheumatology|January 1, 1990
Influence of specific anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of boneJ Y Reginster, C Gennari, C Mautalen, et al.
Pageof 5